Literature DB >> 10797074

Quinolone-induced QT interval prolongation: a not-so-unexpected class effect.

P Ball1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10797074     DOI： 10.1093/jac/45.5.557

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  21 in total

1.  The electro-mechanical window in anaesthetized guinea pigs: a new marker in screening for Torsade de Pointes risk.

Authors:  P-J Guns; D M Johnson; J Van Op den Bosch; E Weltens; J Lissens
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

2.  Role of mixed ion channel effects in the cardiovascular safety assessment of the novel anti-MRSA fluoroquinolone JNJ-Q2.

Authors:  G Eichenbaum; M K Pugsley; D J Gallacher; R Towart; G McIntyre; U Shukla; J M Davenport; H R Lu; J Rohrbacher; V Hillsamer
Journal:  Br J Pharmacol       Date:  2012-07       Impact factor: 8.739

3.  Lack of an effect of standard and supratherapeutic doses of linezolid on QTc interval prolongation.

Authors:  Bharat Damle; Robert R Labadie; Cheryl Cuozzo; Christine Alvey; Heng Wee Choo; Steve Riley; Deborah Kirby
Journal:  Antimicrob Agents Chemother       Date:  2011-06-27       Impact factor: 5.191

4.  A thorough QT study to evaluate the effects of therapeutic and supratherapeutic doses of delafloxacin on cardiac repolarization.

Authors:  Jeffrey S Litwin; Michael S Benedict; Michael D Thorn; Laura E Lawrence; Sue K Cammarata; Eugene Sun
Journal:  Antimicrob Agents Chemother       Date:  2015-04-06       Impact factor: 5.191

Review 5.  Acute exacerbations of chronic bronchitis: what role for the new fluoroquinolones?

Authors:  A Obaji; S Sethi
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

6.  Levofloxacin Use in the Neonate: A Case Series.

Authors:  Brandi D Newby; Kathryn E Timberlake; Lyndsay M Lepp; Tamara Mihic; Deonne A Dersch-Mills
Journal:  J Pediatr Pharmacol Ther       Date:  2017 Jul-Aug

Review 7.  Exposure to antibacterial agents with QT liability in 14 European countries: trends over an 8-year period.

Authors:  Emanuel Raschi; Elisabetta Poluzzi; Chiara Zuliani; Arno Muller; Herman Goossens; Fabrizio De Ponti
Journal:  Br J Clin Pharmacol       Date:  2008-11-17       Impact factor: 4.335

8.  Torsade de pointes associated with moxifloxacin: a rare but potentially fatal adverse event.

Authors:  T Altin; O Ozcan; S Turhan; A Ongun Ozdemir; O Akyurek; R Karaoguz; M Guldal
Journal:  Can J Cardiol       Date:  2007-09       Impact factor: 5.223

9.  Safety of fluoroquinolones: An update.

Authors:  L Mandell; G Tillotson
Journal:  Can J Infect Dis       Date:  2002-01

10.  Evaluation of the effect of a supratherapeutic dose of intravenous ceftaroline fosamil on the corrected QT interval.

Authors:  Todd A Riccobene; Ludmyla Rekeda; Douglas Rank; Lily Llorens
Journal:  Antimicrob Agents Chemother       Date:  2013-01-28       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.